Article Details

Trial of MS1819, Yeast-based EPI Treatment, Opens 2 Sites in Poland

Retrieved on: 2021-02-01 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Trial of MS1819, Yeast-based EPI Treatment, Opens 2 Sites in Poland. View article details on hiswai:

Excerpt

Their addition is intended to minimize delays in enrollment due to the COVID-19 pandemic, AzurRx BioPharma, the treatment's developer, announced.

Article found on: cysticfibrosisnewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up